Correlation Between Parker Hannifin and Pear Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Parker Hannifin and Pear Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Parker Hannifin and Pear Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Parker Hannifin and Pear Therapeutics, you can compare the effects of market volatilities on Parker Hannifin and Pear Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Parker Hannifin with a short position of Pear Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Parker Hannifin and Pear Therapeutics.

Diversification Opportunities for Parker Hannifin and Pear Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Parker and Pear is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Parker Hannifin and Pear Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pear Therapeutics and Parker Hannifin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Parker Hannifin are associated (or correlated) with Pear Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pear Therapeutics has no effect on the direction of Parker Hannifin i.e., Parker Hannifin and Pear Therapeutics go up and down completely randomly.

Pair Corralation between Parker Hannifin and Pear Therapeutics

If you would invest  63,033  in Parker Hannifin on August 30, 2024 and sell it today you would earn a total of  6,955  from holding Parker Hannifin or generate 11.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Parker Hannifin  vs.  Pear Therapeutics

 Performance 
       Timeline  
Parker Hannifin 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Parker Hannifin are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal technical indicators, Parker Hannifin demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Pear Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pear Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pear Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Parker Hannifin and Pear Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Parker Hannifin and Pear Therapeutics

The main advantage of trading using opposite Parker Hannifin and Pear Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Parker Hannifin position performs unexpectedly, Pear Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pear Therapeutics will offset losses from the drop in Pear Therapeutics' long position.
The idea behind Parker Hannifin and Pear Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format